News
Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...
The rapid increase in the use of glucagon-like peptide-1 receptor agonists for weight loss, diabetes management and cardiovascular health has significant implications for orthopedic surgery.GLP-1 ...
So far this year, Pfizer shares have dropped 17.4%, while Novo Nordisk's stock has tumbled 24% and Lilly shares have slipped 3.2%. The SPDR S&P Pharmaceuticals ETF XPH has shed 12.1% year to date and ...
President Donald Trump has ordered federal officials to scour monuments, memorials and statues to remove language he says may "inappropriately disparage Americans," as part of his efforts to fight ...
U.S. stock futures slipped on Monday night as the market awaited clarity from President Donald Trump regarding his tariff policy rollout. Futures tied to the Dow Jones Industrial Average fell by 51 ...
By Gary Trust ROSÉ and Bruno Mars’ “APT.” adds a record-extending 19th week at No. 1 on the Billboard Global Excl. U.S. chart. The collaboration first moved into the top floor in November.
It was last up about 4.6%. Lilly's shares fell more than 3%. Shares of Novo Nordisk, which makes rival GLP-1 drug Wegovy, were down about 2%. Hims had been selling less expensive versions of ...
LE SSERAFIM’s “HOT” moves up 13 spots to take over as the new No. 1 song this week. Congratulations to LE SSERAFIM! “HOT” is the title track from LE SSERAFIM’s fifth mini album of the ...
Hosted on MSN17d
Does Wegovy reduce heart attack risk?Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss. Read more at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results